Twenty years of progress in type 1 diabetes mellitus

IF 40 1区医学 Q1 ENDOCRINOLOGY & METABOLISM

Nature Reviews Endocrinology Pub Date : 2025-09-11 DOI:10.1038/s41574-025-01177-x

Thomas W. H. Kay, Jennifer J. Couper

引用次数: 0

Abstract

Future treatment targets for type 1 diabetes mellitus will be truly normal blood levels of glucose with a minimum of exogenous insulin and no hypoglycaemia. Here, we present some of the landmark trials from the past 20 years that are driving progress to that goal.

Abstract Image

查看原文本刊更多论文

二十年来1型糖尿病的进展

未来1型糖尿病的治疗目标将是真正正常的血糖水平，最低的外源性胰岛素和无低血糖。在这里，我们将介绍过去20年来推动这一目标取得进展的一些里程碑式的试验。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Endocrinology 医学-内分泌学与代谢

CiteScore

42.00

自引率

0.70%

发文量

158

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Endocrinology aspires to be the foremost platform for reviews and commentaries catering to the scientific communities it serves. The journal aims to publish articles characterized by authority, accessibility, and clarity, enhanced with easily understandable figures, tables, and other visual aids. The goal is to offer an unparalleled service to authors, referees, and readers, striving to maximize the usefulness and impact of each article. Nature Reviews Endocrinology publishes Research Highlights, Comments, News & Views, Reviews, Consensus Statements, and Perspectives relevant to researchers and clinicians in the fields of endocrinology and metabolism. Its broad scope ensures that the work it publishes reaches the widest possible audience.